Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Treated With Recombinant von Willebrand Factor in Surgical Settings in the United Kingdom
Results support the effectiveness and safety profile of rVWF in a surgical setting in adults with VWD, supplementing the growing body of evidence for rVWF.
Authors
- Heena Howitt
- Anna Sanigorska (ORCID: https://orcid.org/0000-0001-7993-9501)
- Rosa Willock
- Michael Laffan (ORCID: https://orcid.org/0000-0002-8268-3268)
- Sarah Brighton (ORCID: https://orcid.org/0000-0003-3489-368X)
- Cheryl Jones (ORCID: https://orcid.org/0000-0002-4581-9496)
- Oliver Heard
Institutions
- Hammersmith Hospital (GB)
- Knutsford and District Community Hospital (GB)
- Takeda (United Kingdom) (GB)
- Imperial College London (GB)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-10-11
- DOI
- https://doi.org/10.1111/ejh.70033
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00